Speech-Language Pathologists in Brighton, CO Accepting Medicare

50 Speech-Language Pathologists found. Showing 21 - 40

Saranya Venkataraman Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 975 Platte River Blvd, Brighton, CO 80601 Phone: 720-924-2827

Essence Of Communication, Inc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1606 Prairie Center Pkwy, Suite 120, Brighton, CO 80601 Phone: 303-596-6232

Sarah Welch, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 21 N 1st Ave, Ste 190, Brighton, CO 80601 Phone: 303-659-4090    Fax: 720-230-4875

Pamela Green, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18551 E 160th Ave, Brighton, CO 80601 Phone: 303-655-2900

Carol I Chadwick, Ms,ccc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1606 Prairie Center Pkwy Ste 120, Brighton, CO 80601 Phone: 303-659-4090    Fax: 720-685-9114

Melissa Brooks, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18551 E 160th Ave, Brighton, CO 80601 Phone: 303-655-2920

Kayla Slofkiss Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18551 E 160th Ave, Brighton, CO 80601 Phone: 303-655-2900

Mrs. Kathryn Devero Maciula, M.S., CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 975 Platte River Blvd, Suite O, Brighton, CO 80601 Phone: 303-659-7788

Rachel Ricca, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 975 Platte River Blvd, Unit O, Brighton, CO 80601 Phone: 303-659-8822

Ann Marie Johnston, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 975 Platte River Blvd, Unit O, Brighton, CO 80601 Phone: 303-659-8822    Fax: 303-659-7788

Lillie Alsky Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1287 S 8th Ave Unit 238, Brighton, CO 80601 Phone: 760-987-0706

Mrs. Michelle Renee Hayden, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1606 Prairie Center Pkwy, Suite 120, Brighton, CO 80601 Phone: 303-659-4090

Claire Marie Martin, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18551 E 160th Ave, Brighton, CO 80601 Phone: 303-655-2900

Victoria Bartter, MS,CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18551 E 160th Ave, Brighton, CO 80601 Phone: 303-655-2900

Kaitlyn Eileen Warnick, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 21 N 1st Ave Ste 190, Brighton, CO 80601 Phone: 303-659-4090

Mrs. Christine Grimaldi Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6624 Monaco Way, Brighton, CO 80602 Phone: 303-565-6682

Lori Morris, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1733 Wildflower Dr, Brighton, CO 80601 Phone: 720-290-6800

Vittoria Mary Strub Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 975 Platte River Blvd Unit O, Brighton, CO 80601 Phone: 303-659-8822

Adina Gonzales, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18551 E 160th Ave, Brighton, CO 80601 Phone: 303-655-5158

Naomi Y Ito Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 975 Platte River Blvd Unit O, Brighton, CO 80601 Phone: 303-659-8822    Fax: 303-659-7788

News Archive

Study finds abnormal expression of miRNAs can contribute to human diseases

Researchers at Tufts University School of Medicine and Tufts Medical Center have identified an RNA sequence that promotes increased numbers of specific microRNAs (miRNAs), molecules that regulate cell growth, development, and stress response. The discovery helps researchers understand the links between miRNA expression and disease, including heart disease and cancer. The findings are published in the August 13 issue of Molecular Cell.

Washington University receives award to develop diagnostic tools for heart, lung diseases using nanotechnology

An $18 million research program headed by Washington University School of Medicine in St. Louis will research therapies and diagnostic tools for heart and lung diseases that use nanotechnology.

Cognitive behavioral therapy can be equally effective as second generation antidepressant for depression

Major depressive disorder affects more than 32 million Americans, and their first stop for treatment is often their primary care provider. A recent evidence review of several alternatives to medication found that using cognitive behavioral therapy as the first treatment for depression can be equally effective as using a second generation antidepressant.

First randomized clinical trial compares targeted therapies for acute lymphoblastic leukemia

Researchers from St. Jude Children's Research Hospital and the Chinese Children's Cancer Group led the first randomized, Phase III clinical trial comparing targeted therapies for acute lymphoblastic leukemia (ALL) driven by the Philadelphia chromosome.

Cempra Pharmaceuticals completes Phase 1 clinical trials of CEM-101 macrolide

Cempra Pharmaceuticals today announced the successful completion of Phase 1 clinical trials of its oral formulation of CEM-101, which showed good tolerability in those studies. The company also announced plans to submit an IND to the FDA to begin a Phase 1 study with the company's intravenous formulation of CEM-101 in mid-2010.

Read more Medical News

› Verified 6 days ago

• 1
• 2(current)
• 3